PATIENT VOICES, a project for the integration of the systematic assessment of patient reported outcomes and experiences within a comprehensive cancer center: a protocol for a mixed method feasibility study.


Journal

Health and quality of life outcomes
ISSN: 1477-7525
Titre abrégé: Health Qual Life Outcomes
Pays: England
ID NLM: 101153626

Informations de publication

Date de publication:
28 Jul 2020
Historique:
received: 09 01 2020
accepted: 20 07 2020
entrez: 30 7 2020
pubmed: 30 7 2020
medline: 5 11 2020
Statut: epublish

Résumé

Listening to "patient voices" in terms of symptoms, emotional status and experiences with care, is crucial for patient empowerment in clinical practice. Despite convincing evidence that routine patient reported outcomes and experience measurements (PRMs) with rapid feed-back to oncologists can improve symptom control, patient well-being and cost effectiveness, PRMs are not commonly used in cancer care, due to barriers at various level. Part of these barriers may be overcome through electronic PRMs collection (ePRMs) integrated with the electronic medical record (EMR). The PATIENT VOICES initiative is aimed at achieving a stepwise integration of ePRMs assessment into routine cancer care. The feasibility project presented here is aimed at assessing the knowledge, use and attitudes toward PRMs in a comprehensive cancer centre; developing and assessing feasibility of a flexible system for ePRM assessment; identifying barriers to and developing strategies for implementation and integration of ePRMs clinical practice. The project has been organized into four phases: a) pre-development; b) software development and piloting; c) feasibility assessment; d) post-development. A convergent mixed method design, based on concurrent quantitative and qualitative data collection will be applied. A web-survey on health care providers (HCPs), qualitative studies on patients and HCPs (semi-structured interviews and focus groups) as well as longitudinal and cross-sectional quantitative studies will be carried out. The quantitative studies will enroll 600 patients: 200 attending out-patient clinics (physical symptom assessement), 200 attending inpatient wards (psychological distress assessment) and 200 patients followed by multidisciplinary teams (patient experience with care assessment). The Edmonton symptom assessment scale, the Distress Thermometer, and a tool adapted from existing patient reported experience with cancer care questionnaires, will be used in quantitative studies. A multi-disciplinary stakeholder team including researchers, clinicians, health informatics professionals, health system administrators and patients will be involved in the development of potentially effective implementation strategies in the post development phase. The documentation of potential advantages and implementation barriers achieved within this feasibility project, will serve as a starting point for future and more focused interventions aimed at achieving effective ePRMs routine assessment in cancer care. ClinicalTrials.gov ( NCT03968718 ) May 30th, 2019.

Sections du résumé

BACKGROUND BACKGROUND
Listening to "patient voices" in terms of symptoms, emotional status and experiences with care, is crucial for patient empowerment in clinical practice. Despite convincing evidence that routine patient reported outcomes and experience measurements (PRMs) with rapid feed-back to oncologists can improve symptom control, patient well-being and cost effectiveness, PRMs are not commonly used in cancer care, due to barriers at various level. Part of these barriers may be overcome through electronic PRMs collection (ePRMs) integrated with the electronic medical record (EMR). The PATIENT VOICES initiative is aimed at achieving a stepwise integration of ePRMs assessment into routine cancer care. The feasibility project presented here is aimed at assessing the knowledge, use and attitudes toward PRMs in a comprehensive cancer centre; developing and assessing feasibility of a flexible system for ePRM assessment; identifying barriers to and developing strategies for implementation and integration of ePRMs clinical practice.
METHODS METHODS
The project has been organized into four phases: a) pre-development; b) software development and piloting; c) feasibility assessment; d) post-development. A convergent mixed method design, based on concurrent quantitative and qualitative data collection will be applied. A web-survey on health care providers (HCPs), qualitative studies on patients and HCPs (semi-structured interviews and focus groups) as well as longitudinal and cross-sectional quantitative studies will be carried out. The quantitative studies will enroll 600 patients: 200 attending out-patient clinics (physical symptom assessement), 200 attending inpatient wards (psychological distress assessment) and 200 patients followed by multidisciplinary teams (patient experience with care assessment). The Edmonton symptom assessment scale, the Distress Thermometer, and a tool adapted from existing patient reported experience with cancer care questionnaires, will be used in quantitative studies. A multi-disciplinary stakeholder team including researchers, clinicians, health informatics professionals, health system administrators and patients will be involved in the development of potentially effective implementation strategies in the post development phase.
DISCUSSION CONCLUSIONS
The documentation of potential advantages and implementation barriers achieved within this feasibility project, will serve as a starting point for future and more focused interventions aimed at achieving effective ePRMs routine assessment in cancer care.
TRIAL REGISTRATION BACKGROUND
ClinicalTrials.gov ( NCT03968718 ) May 30th, 2019.

Identifiants

pubmed: 32723341
doi: 10.1186/s12955-020-01501-1
pii: 10.1186/s12955-020-01501-1
pmc: PMC7388528
doi:

Banques de données

ClinicalTrials.gov
['NCT03968718']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

252

Subventions

Organisme : Ministero della Salute
ID : 5x1000 Funds - 2015 - ID code D171CB

Investigateurs

Giovanni Apolone (G)
Marco Bellazzi (M)
Filiberto Belli (F)
Claudia Borreani (C)
Cinzia Brunelli (C)
Giuseppe Capri (G)
Augusto Caraceni (A)
Paolo Casali (P)
Paolo Corradini (P)
Filippo de Braud (F)
Anna Maria Foschi (AM)
Secondo Folli (S)
Marina Garassino (M)
Lisa Licitra (L)
Nicola Nicolai (N)
Chiara Pellegrini (C)
Marco Platania (M)
Giuseppe Procopio (G)
Anna Roli (A)
Roberto Salvioni (R)
Pierangelo Spada (P)
Riccardo Valdagni (R)
Emanuela Zito (E)

Références

J Patient Rep Outcomes. 2018 Oct 3;2:46
pubmed: 30363333
Health Aff (Millwood). 2013 Feb;32(2):223-31
pubmed: 23381514
Ann Oncol. 2001;12 Suppl 3:S7-10
pubmed: 11804386
Support Care Cancer. 2015 Jul;23(7):2189-202
pubmed: 25894883
J Clin Oncol. 2011 Mar 10;29(8):954-6
pubmed: 21282536
N Engl J Med. 2017 Jan 12;376(2):105-108
pubmed: 28076708
Health Qual Life Outcomes. 2004 Jun 29;2:32
pubmed: 15225377
Nurse Res. 2014 Jan;21(3):24-6
pubmed: 24460562
J Patient Rep Outcomes. 2018 Dec 27;2(1):64
pubmed: 30588562
Cancer. 2013 Dec 15;119(24):4333-40
pubmed: 24114037
Health Qual Life Outcomes. 2006 Oct 11;4:79
pubmed: 17034633
JAMA Oncol. 2016 Apr;2(4):433-4
pubmed: 26720842
Syst Rev. 2018 Feb 20;7(1):32
pubmed: 29463298
Palliat Med. 2008 Mar;22(2):111-22
pubmed: 18372376
Med Care. 2019 May;57 Suppl 5 Suppl 1:S92-S99
pubmed: 30985602
J R Soc Med. 2015 Aug;108(8):299-303
pubmed: 25827908
Cancer. 1998 May 15;82(10):1904-8
pubmed: 9587123
Ann Intern Med. 2009 Aug 18;151(4):264-9, W64
pubmed: 19622511
J Affect Disord. 2009 Apr;114(1-3):193-9
pubmed: 18757101
J Oncol Pract. 2017 Aug;13(8):515-518
pubmed: 28737962
Support Care Cancer. 2018 Jan;26(1):41-60
pubmed: 28849277
J Thorac Oncol. 2019 Jun;14(6):1012-1020
pubmed: 30776447
Support Care Cancer. 2006 Jan;14(1):30-7
pubmed: 15937688
Lancet Oncol. 2018 Nov;19(11):e588-e653
pubmed: 30344075
Patient Educ Couns. 2016 Apr;99(4):483-490
pubmed: 26603445
J Natl Cancer Inst. 2017 Sep 1;109(9):
pubmed: 28423407
J Clin Oncol. 2016 Feb 20;34(6):557-65
pubmed: 26644527
Qual Life Res. 2009 Feb;18(1):115-23
pubmed: 19105048
J Gen Intern Med. 2017 Jun;32(6):640-647
pubmed: 28160187
Res Nurs Health. 1996 Dec;19(6):525-9
pubmed: 8948406
BMJ. 2012 Jan 27;344:e256
pubmed: 22286508
Nurs Res. 1991 Mar-Apr;40(2):120-3
pubmed: 2003072
JAMA. 2017 Jul 11;318(2):197-198
pubmed: 28586821
Syst Rev. 2015 Jul 23;4:97
pubmed: 26202326
Cancer. 2011 Feb 15;117(4):854-61
pubmed: 20922802
J Clin Oncol. 2014 May 10;32(14):1480-501
pubmed: 24711559
JCO Clin Cancer Inform. 2017 Nov;1:1-14
pubmed: 30657392
BMC Cancer. 2016 Sep 02;16(1):711
pubmed: 27589989
J Oncol Pract. 2014 Jul;10(4):e215-22
pubmed: 24301843

Auteurs

Cinzia Brunelli (C)

Palliative Care, Pain Therapy and Rehabilitation Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.

Claudia Borreani (C)

Clinical psychology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Augusto Caraceni (A)

Palliative Care, Pain Therapy and Rehabilitation Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.

Anna Roli (A)

Quality, education and data protection Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Marco Bellazzi (M)

Information and communication technology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy.

Linda Lombi (L)

Department of Sociology, Università Cattolica del Sacro Cuore, Milan, Italy.

Emanuela Zito (E)

Information and communication technology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy. emanuela.zito@istitutotumori.mi.it.

Chiara Pellegrini (C)

Palliative Care, Pain Therapy and Rehabilitation Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.

Pierangelo Spada (P)

Nursing, technical and rehabilitation services Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Stein Kaasa (S)

European Palliative Care Research Centre (PRC), Department of Oncology, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Anna Maria Foschi (AM)

Patient representative, Scientific Directorate, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Giovanni Apolone (G)

Scientific Directorate, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH